Delivery Order SPE2DB24D2003-SPE2DB25FXGU6
Award Date
4/15/25
Potential Completion Date
4/16/25
Potential Value
$6.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,340.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to...
This federal contract award, valued at $2,552.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the medication Trulicity 1.5 mg/0.5 ml pen, a treatment for diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp also holds a significant Indefinite...
This federal contract award, valued at $3,245.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Trulicity 1.5 mg/0.5 ml pen, which is used to treat diabetes. The contract has an ultimate completion date of January 24, 2022 and utilizes a firm fixed price pricing type. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,280.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to $999,999,999.00, serves as...
This federal contract award, valued at $13,933.44, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award, valued at $8,708.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,150 units of Trulicity 3 mg/0.5 mL pens, a medication used to treat diabetes. This award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The IDC enables the government...
This federal contract award, valued at $3,245.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of September 16, 2022. This award is associated with a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,338.97 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive...
This federal contract award, valued at $16,318.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The award is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November...
This federal contract award, valued at $5,370.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The award has an ultimate completion date of January 29, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a...